Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr:28:200-212.
doi: 10.1016/j.jtos.2023.04.009. Epub 2023 Apr 11.

TFOS Lifestyle - Evidence quality report: Advancing the evaluation and synthesis of research evidence

Affiliations

TFOS Lifestyle - Evidence quality report: Advancing the evaluation and synthesis of research evidence

Laura E Downie et al. Ocul Surf. 2023 Apr.

Abstract

Evidence-based practice is a dominant paradigm in healthcare that emphasizes the importance of ensuring the translation of the best available, relevant research evidence into practice. An Evidence Quality Subcommittee was established to provide specialized methodological support and expertise to promote rigorous and evidence-based approaches for the Tear Film and Ocular Surface Society (TFOS) Lifestyle Epidemic reports. The present report describes the purpose, scope, and activity of the Evidence Quality Subcommittee in the undertaking of high-quality narrative-style literature reviews, and leading prospectively registered, reliable systematic reviews of high priority research questions, using standardized methods for each topic area report. Identification of predominantly low or very low certainty evidence across the eight systematic reviews highlights a need for further research to define the efficacy and/or safety of specific lifestyle interventions on the ocular surface, and to clarify relationships between certain lifestyle factors and ocular surface disease. To support the citation of reliable systematic review evidence in the narrative review sections of each report, the Evidence Quality Subcommittee curated topic-specific systematic review databases and relevant systematic reviews underwent standardized reliability assessment. Inconsistent methodological rigor was noted in the published systematic review literature, emphasizing the importance of internal validity assessment. Based on the experience of implementing the Evidence Quality Subcommittee, this report makes suggestions for incorporation of such initiatives in future international taskforces and working groups. Content areas broadly relevant to the activity of the Evidence Quality Subcommittee, including the critical appraisal of research, clinical evidence hierarchies (levels of evidence), and risk of bias assessment, are also outlined.

Keywords: AMSTAR; Cochrane; Critical appraisal; Evidence hierarchy; Evidence synthesis; Evidence-based practice; Meta-analysis; Ocular surface; Risk of bias; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Laura E. Downie: Alcon (F), Azura Ophthalmics (F), BCLA (R), CooperVision (F), Cornea and Contact Lens Society of Australia (R), Medmont International (R), NHMRC Australia (F), Novartis (F), TFOS (S); Alexis Ceecee Britten-Jones: Plano (R); Ruth E Hogg: None; Isabelle Jalbert: Johnson & Johnson Vision (F), Diabetes Australia (F); Specsavers (R), University of Melbourne (R), Australian College of Optometry (R), Optometry Council of Australia and New Zealand (S), New South Wales Optometry Council (S); Tianjing Li: National Eye Institute, National Institutes of Health (F); Gareth Lingham: None; Su-Hsun Liu: None; Riaz Qureshi: None; Ian J Saldanha: None; Sumeer Singh: None; Jennifer P Craig: Adelphi Values Ltd (R), Alcon (F,R,C), Asta Supreme (R), Azura Ophthalmics (F,R), E-Swin (F,R), Johnson & Johnson Vision (R), Laboratoires Théa (F,R), Manuka Health NZ (F), Medmont International (R), Novoxel (R), Oculeve (F), Photon Therapeutics (R), Resono Ophthalmic (F,R), TFOS (S), Topcon (F,R), TRG Natural Pharmaceuticals (F,R).

Figures

Fig. 1.
Fig. 1.
Representative evidence hierarchy for Intervention research questions, based on the National Health and Medical Research Council of Australia schema [9]. Image taken from the CrowdCARE database [7] tutorial.
Fig. 2.
Fig. 2.
PRISMA flow diagram summarizing the identification and reliability assessment of systematic review citations derived from the Cochrane Eyes and Vision United States Project (CEV@US) Database of Systematic Reviews in Eyes and Vision to populate systematic review databases for the TFOS Lifestyle Epidemic Workshop topic area narrative reviews.
Fig. 3.
Fig. 3.
Number of systematic reviews published on topics broadly relevant to the ocular surface and lifestyle factors, stratified by whether they were assessed as reliable or unreliable using a ‘rapid reliability assessment tool’ [42]. *Note: 2021 is an incomplete year (up to August 2021, in alignment with the Workshop time frame).

Similar articles

Cited by

References

    1. Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II report executive summary. Ocul Surf 2017;15:802–12. - PubMed
    1. Nichols JJ, Willcox MD, Bron AJ, Belmonte C, Ciolino JB, Craig JP, et al. The TFOS international Workshop on contact lens discomfort: executive summary. Invest Ophthalmol Vis Sci 2013;54. Tfos7–tfos13. - PMC - PubMed
    1. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international Workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011;52:1922–9. - PMC - PubMed
    1. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop. Ocul Surf 2007;5:75–92. 2007. - PubMed
    1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71–2. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources